ArticleClinical lung cancer2018

First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance.

Wade T Iams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.